ArticleClinical drug investigation2020

Cost Effectiveness of Ceritinib and Alectinib Versus Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-small-cell Lung Cancer.

Hongchao Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.